Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	16.23	91.92	79.08
Graham Fair Price	-24.16	24.49	32.30
PEG	241.96	-1.19	0.35
Price/Book	12.33	3.05	2.72
Price/Cash Flow	2611.11	2074.14	76.51
Prices/Earnings	95.85	50.84	25.96
Price/Sales	17.42	15.30	13.03
Price/FCF	2611.11	2074.14	76.51
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.41	0.37	0.36
Operating Margin	-1.59	0.11	0.11
ROA	-41.80	< 0.005	0.02
ROE	0.03	0.02	-42.64
ROIC	0.02	0.01	-41.87
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.11	0.17	-37.35
Dividends QOQ	< 0.005	0.10	3648.57
EBIT QOQ	0.53	-0.06	-89.53
EPS QOQ	0.75	-0.43	-42.73
FCF QOQ	0.21	-0.96	362.22
Revenue QOQ	0.02	-0.04	95.94
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	67.37	73.05	8.44
Days Sales Outstanding (DSO)	68.68	72.65	5.78
Inventory Turnover	1.34	1.23	-7.78
Debt/Capitalization	0.19	0.19	-0.77
Quick Ratio	1.20	1.11	-7.13
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	42.09	42.15	0.14
Cash	4.22	3.92	-7.20
Capex	-0.39	-0.31	21.39
Free Cash Flow	1.49	0.06	-95.85
Revenue	8.77	8.41	-4.20
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.76	1.67	-5.19
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.44	4.03	-9.22
Naive Interpretation	Member

06 - Financial Health · Weak

Rating